NasdaqGM:PRCTMedical Equipment
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives
PROCEPT BioRobotics (PRCT) opened Q1 2026 with total revenue of US$83.1 million and a basic EPS loss of US$0.56, while trailing twelve month figures showed revenue of US$322.0 million and a basic EPS loss of US$1.83, keeping profitability firmly in focus for investors. Over recent quarters the company has seen revenue move from US$69.2 million in Q1 2025 to US$83.1 million in Q1 2026, alongside quarterly basic EPS losses ranging from US$0.35 to US$0.56, so the market is likely to zero in on...